Surfactant protein B and A concentrations are increased in neonatal pneumonia

Background:Term newborns with pneumonia show a reduced pulmonary compliance due to multiple and ill-defined factors. Surfactant proteins’ (SPs) changes could have a role in the reduced compliance but the matter is still unsettled. The aim of this study was to clarify the meaning of SPs changes during pneumonia in term newborns.Methods:In 28 term ventilated newborns, 13 with pneumonia and 15 with no lung disease, we measured SP-B, SP-A, disaturated-phosphatidylcholine (DSPC), and total phospholipids (PL) concentrations in tracheal aspirates at intubation and close to extubation. We also measured DSPC kinetics using (U-13C-PA)dipalmitoyl-phosphatidylcholine.Results:At baseline, SP-B, expressed as % of PL, was significantly different between the groups, being 3.5-fold higher in pneumonia than controls. Conversely, SP-A did not vary between the groups. At extubation, SP-B and SP-A concentrations had decreased significantly in newborns with pneumonia, while there was no significant change in controls. DSPC t1/2 was significantly shorter in the pneumonia group (11.8 (5.5–19.8) h vs. 26.6 (19.3–63.6) h, P = 0.011).Conclusion:In term newborns with pneumonia, SP-B increases with respect to PL, and DSPC is turned over at a faster rate. Disease’s resolution is associated with the restoration of the normal ratio between SP-B and PL.

[1]  W. Seeger,et al.  Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children , 2003, Critical care medicine.

[2]  J. Whitsett,et al.  Pulmonary collectins and innate host defense of the lung. , 2001, Microbes and infection.

[3]  C. Cobelli,et al.  Dexamethasone Therapy in Preterm Infants Developing Bronchopulmonary Dysplasia: Effect on Pulmonary Surfactant Disaturated-Phosphatidylcholine Kinetics , 2008, Pediatric Research.

[4]  W. Seeger,et al.  ELISA technique for quantification of surfactant protein B (SP-B) in bronchoalveolar lavage fluid. , 1995, American journal of respiratory and critical care medicine.

[5]  A. Postle,et al.  Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[6]  P. Cogo,et al.  In Vivo Effect of Pneumonia on Surfactant Disaturated-Phosphatidylcholine Kinetics in Newborn Infants , 2014, PloS one.

[7]  B. Stripp,et al.  Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Dargaville,et al.  Validity of markers of dilution in small volume lung lavage. , 1999, American journal of respiratory and critical care medicine.

[9]  G. R. Bartlett.  Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.

[10]  M. Griese,et al.  Cardiopulmonary bypass reduces pulmonary surfactant activity in infants. , 1999, The Journal of thoracic and cardiovascular surgery.

[11]  A. Clément,et al.  Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. , 2000 .

[12]  J. Pérez-Gil,et al.  Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions. , 2008, Biochimica et biophysica acta.

[13]  P. Sauer,et al.  Simultaneous Measurement of the Rates of Appearance of Palmitic and Linoleic Acid in Critically Ill Infants , 1997, Pediatric Research.

[14]  L. Vedovelli,et al.  Pulmonary surfactant synthesis after unilateral lung injury in mice. , 2014, Journal of applied physiology.

[15]  W. Seeger,et al.  Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. , 1996, American journal of respiratory and critical care medicine.

[16]  J. Whitsett,et al.  Increased expression of pulmonary surfactant proteins in oxygen-exposed rats. , 1991, American journal of respiratory cell and molecular biology.

[17]  V. Poletti,et al.  Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage. , 1996, American journal of respiratory and critical care medicine.

[18]  H. Colten,et al.  Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. , 1993, The New England journal of medicine.

[19]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[20]  C. Cobelli,et al.  Surfactant disaturated-phosphatidylcholine kinetics in acute respiratory distress syndrome by stable isotopes and a two compartment model , 2007, Respiratory research.

[21]  A. Jobe,et al.  Surfactant treatment and ventilation effects on surfactant SP-A, SP-B, and SP-C mRNA levels in preterm lamb lungs. , 1995, The American journal of physiology.

[22]  L. Nogee.  Genetics of the hydrophobic surfactant proteins. , 1998, Biochimica et biophysica acta.

[23]  A. Pettenazzo,et al.  SP-A, SP-B, and SP-C in surfactant subtypes around birth: reexamination of alveolar life cycle of surfactant. , 1994, The American journal of physiology.

[24]  C. Ruppert,et al.  An ELISA technique for quantification of surfactant apoprotein (SP)-C in bronchoalveolar lavage fluid. , 1995, American journal of respiratory and critical care medicine.

[25]  Motoko Takahashi,et al.  Pulmonary collectins in innate immunity of the lung , 2007, Cellular microbiology.

[26]  M. Grocott,et al.  Phospholipid composition and kinetics in different endobronchial fractions from healthy volunteers , 2014, BMC Pulmonary Medicine.

[27]  M. Pollack,et al.  Surfactant content in children with inflammatory lung disease. , 1996, Critical care medicine.

[28]  J. Paton,et al.  Surfactant protein levels in severe respiratory syncytial virus infection. , 1999, American journal of respiratory and critical care medicine.

[29]  C. R. Reed,et al.  Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. , 1991, The Journal of clinical investigation.

[30]  J. Whitsett,et al.  STAT-3 regulates surfactant phospholipid homeostasis in normal lung and during endotoxin-mediated lung injury. , 2008, Journal of applied physiology.

[31]  P. Dargaville,et al.  Surfactant abnormalities in infants with severe viral bronchiolitis. , 1996, Archives of disease in childhood.

[32]  P. Sauer,et al.  Exogenous surfactant kinetics in infant respiratory distress syndrome: A novel method with stable isotopes. , 2000, American journal of respiratory and critical care medicine.

[33]  A. Pettenazzo,et al.  Uptake and degradation of Curosurf after tracheal administration to newborn and adult rabbits. , 1998, The European respiratory journal.

[34]  M. Derrick,et al.  Structure and properties of surfactant protein B. , 1998, Biochimica et biophysica acta.

[35]  A. Jobe,et al.  Surfactant protein B inhibits endotoxin-induced lung inflammation. , 2003, American journal of respiratory cell and molecular biology.

[36]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[37]  M. Avery,et al.  Surface properties in relation to atelectasis and hyaline membrane disease. , 1959, A.M.A. journal of diseases of children.

[38]  M. Beers,et al.  Surfactant protein C: its unique properties and emerging immunomodulatory role in the lung. , 2006, Microbes and infection.